Therapeutic materials used in the treatment of coagulation defects.
D001778:Blood Coagulation Disorders / Q000628:therapy*; D011232:Chemical Precipitation; D003450:Cryoglobulins; D005164:Factor IX / Q000627:therapeutic use; D005165:Factor V / Q000627:therapeutic use; D005167:Factor VII / Q000627:therapeutic use; D005169:Factor VIII / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D005170:Factor X / Q000627:therapeutic use; D005172:Factor XI / Q000627:therapeutic use; D005174:Factor XII / Q000627:therapeutic use; D005176:Factor XIII / Q000627:therapeutic use; D005340:Fibrinogen / Q000627:therapeutic use; D005612:Freeze Drying; D006509:Hepatitis B / Q000635:transmission; D006801:Humans; D011516:Prothrombin / Q000627:therapeutic use; D014842:von Willebrand Diseases / Q000628:therapy
D003450:Cryoglobulins; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005174:Factor XII; D005340:Fibrinogen; D005172:Factor XI; D005176:Factor XIII